Showing results (1001-1010 of 8,791) with videos related to

Sort By:
Pageof 880
Pediatric Blood & Cancer|May 2, 2013
Acute care of pediatric patients with sickle cell disease: a simulation performance assessmentTracy L Burns, Michael R DeBaun, John R Boulet, et al.
Pediatric Blood & Cancer|March 15, 2013
Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and BotswanaCarrie M Cox, Nader Kim El-Mallawany, Mark Kabue, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|January 22, 2013
GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosisJian-Rong Wu, Li-Xing Yuan, Zhi-Gui Ma, et al.
Pediatric Blood & Cancer|January 22, 2013
Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costsMorey A Blinder, Francis Vekeman, Medha Sasane, et al.
Pediatric Blood & Cancer|January 22, 2013
SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countriesGuillermo Chantada, Sandra Luna-Fineman, Rita S Sitorus, et al.
Pediatric Blood & Cancer|January 22, 2013
Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastomaIrene Y Cheung, Yi Feng, Nai-Kong V Cheung
Pediatric Blood & Cancer|January 22, 2013
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008)Ellis J Neufeld, Kapil Saxena, Craig M Kessler, et al.
Pediatric Blood & Cancer|January 22, 2013
Hospital-based home care for children with cancer: feasibility and psychosocial impact on children and their familiesHelena Hansson, Hanne Kjaergaard, Christoffer Johansen, et al.
Pediatric Blood & Cancer|January 22, 2013
Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeMegan E Burke, Elizabeth R Lyden, Jane L Meza, et al.
Pageof 880